SynthesisJournal of neuroinflammation2024

The role of alemtuzumab in the development of secondary autoimmunity in multiple Sclerosis: a systematic review.

Sofia Jimenez-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.